Navigation
Market Outlook Stock Screener Dividend Calendar Event Calendar Rating of shares Markets News
Try free

AcelRx Pharmaceuticals

NASDAQ ACRX
- - -%
Today share price
USA
Sector: Healthcare Industry: Pharmaceuticals
Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Rating Finrange

Index: 12 %
Market cap

Market capitalization – refers to the total value of all a company's shares of stock. It is calculated by multiplying the price of a stock by its total number of outstanding shares.

19.12M
EV

Enterprise value is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. Enterprise value includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.
13.40M
Beta

Beta is one of the most popular indicators of risk is a statistical measure. Analysts use this measure often when they need to determine a stock's risk profile.
0.88
Shares

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company’s insiders.
16.95M
YTD

Year to date (YTD) refers to the period of time beginning the first day of the current calendar year or fiscal year up to the current date. he acronym often modifies concepts such as investment returns and price change.
53.43 %

Upcoming events AcelRx Pharmaceuticals

All events
No upcoming events scheduled

Overview

Financials

Key Metrics

Dividends

Industry overview

Events

Stock chart AcelRx Pharmaceuticals

Stock analysis AcelRx Pharmaceuticals

Indicator Company Industry
P/E (LTM)

Shows how many years the investor's investment in the company will pay off with a profit over the last 12 months.

More
-3.90 8.79
P/BV (LTM)

Shows the ratio of the market price of the share to the current book value.

More
1.36 25.38
EV/EBITDA (LTM)

Represents the ratio of the company's value to its pre-tax EBITDA in the last 12 months.

More
-1.21 4.40
Net Debt/EBITDA (LTM)

A company's debt ratio, which indicates how long the company will need to run on cash flow in the past 12 months to pay off its own debt.

More
0.52 0.50
ROE (LTM)

Shows the efficiency of using the share capital by the company. In other words, ROE shows how much of the company's net profit for the invested capital over the last 12 months.

More
-34.80 9.54

Price change AcelRx Pharmaceuticals per year

0.97$ 2.94$
Min Max

Summary analysis AcelRx Pharmaceuticals

Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Shareholder structure AcelRx Pharmaceuticals

Revenue and net income AcelRx Pharmaceuticals

All parameters

Stock news AcelRx Pharmaceuticals

All news
14 March 2023 в 15:57

AcelRx Pharmaceuticals Shares Rise Premarket on Dsuvia Sale >ACRX

14 March 2023 в 15:57

AcelRx Pharmaceuticals Shares Rise Premarket on Dsuvia Sale >ACRX

15 November 2021 в 14:35

AcelRx Pharmaceuticals to Buy Lowell Therapeutics in $32.5 Million Deal >ACRX

15 November 2021 в 14:35

AcelRx Pharmaceuticals to Buy Lowell Therapeutics in $32.5 Million Deal >ACRX

About company AcelRx Pharmaceuticals

AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute pain. The company's lead product candidate is DSUVIA, a 30 mcg sufentanil sublingual tablet for the treatment of moderate-to-severe acute pain. It also develops ZALVISO, a pre-programmed and patient-controlled analgesia system that allows hospital patients with moderate-to-severe acute pain to self-dose with sufentanil sublingual tablets to manage their pain. The company was formerly known as SuRx, Inc. and changed its name to AcelRx Pharmaceuticals, Inc. in August 2006. AcelRx Pharmaceuticals, Inc. was founded in 2005 and is based in Hayward, California.
Address:
25821 Industrial Boulevard, Hayward, CA, United States, 94545
Company name: AcelRx Pharmaceuticals
Issuer ticker: ACRX
ISIN: US00444T1007
Country: USA
Exchange: NASDAQ
Currency: $
IPO date: 2011-02-14
Sector: Healthcare
Industry: Pharmaceuticals
Site: https://www.acelrx.com

On which stock exchange are AcelRx Pharmaceuticals (ACRX) stocks traded?

AcelRx Pharmaceuticals (ACRX) stocks are traded on NASDAQ.

What is the ticker of AcelRx Pharmaceuticals stocks (ACRX)?

The stock ticker of AcelRx Pharmaceuticals’s stocks or in other words, the code is ACRX. The stocks are currently listed on the NASDAQ exchange.

In which sector and industry does AcelRx Pharmaceuticals (ACRX) operate?

According to the GICS (Global Industry Classification Standard) classification developed jointly by MSCI and Standard & Poor's, AcelRx Pharmaceuticals (ACRX) belongs to the «Healthcare» sector and the «Pharmaceuticals» industry.

In what currency are AcelRx Pharmaceuticals (ACRX) stocks traded?

AcelRx Pharmaceuticals (ACRX) stocks are traded on the NASDAQ exchange in dollars.

What is the price of AcelRx Pharmaceuticals (ACRX) stocks today?

The current price of AcelRx Pharmaceuticals stocks on 15.05.2024 is dollars. per share.

What is the dynamics of AcelRx Pharmaceuticals (ACRX) stocks from the beginning of the year?

AcelRx Pharmaceuticals (ACRX) quotes have increased by -100% from the beginning of the year up to dollars. per 1 stocks.

How much did AcelRx Pharmaceuticals (ACRX) stocks increase in мае 2024?

This month AcelRx Pharmaceuticals (ACRX) quotes have increased by 0% to dollars. per share.

How much are AcelRx Pharmaceuticals (ACRX) stocks worth?

Today, on October, 15.05.2024 AcelRx Pharmaceuticals’s (ACRX) stocks cost dollars..

What is the market capitalization of AcelRx Pharmaceuticals (ACRX)?

Capitalization is the market value of AcelRx Pharmaceuticals (ACRX) is calculated as the number of issued stocks multiplied on the current quotation price. Thus, on 15.05.2024, the market capitalization of AcelRx Pharmaceuticals (ACRX) is estimated at about 19117356 dollars.